| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 3.524 | 556 | 13.809 | 4.760 | 10.780 | 8.600 | 3.395 |
| Total Income - EUR | - | - | 1.189 | 11.806 | 22.474 | 55.715 | 85.999 | 102.218 | 107.570 | 75.560 |
| Total Expenses - EUR | - | - | 585 | 11.234 | 18.447 | 50.825 | 77.221 | 94.103 | 101.805 | 74.184 |
| Gross Profit/Loss - EUR | - | - | 605 | 572 | 4.027 | 4.891 | 8.778 | 8.115 | 5.765 | 1.376 |
| Net Profit/Loss - EUR | - | - | 605 | 537 | 4.021 | 4.726 | 8.736 | 8.021 | 5.692 | 1.325 |
| Employees | - | - | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Livada Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 8.748 | 54.615 | 164.939 | 288.142 | 392.331 | 382.997 | 321.548 | 383.533 |
| Current Assets | - | - | 8 | 32.444 | 9.068 | 16.939 | 110.119 | 59.424 | 221.089 | 191.576 |
| Inventories | - | - | 0 | 1.235 | 1.506 | 25 | 6.931 | 3.540 | 3.230 | 6.899 |
| Receivables | - | - | 0 | 7.990 | 4.162 | 12.954 | 27.779 | 51.453 | 213.236 | 135.200 |
| Cash | - | - | 8 | 23.219 | 3.401 | 3.959 | 75.410 | 4.430 | 4.623 | 49.477 |
| Shareholders Funds | - | - | 648 | 1.195 | 5.193 | 9.821 | 18.340 | 26.418 | 32.070 | 33.216 |
| Social Capital | - | - | 44 | 64 | 63 | 62 | 61 | 61 | 101 | 101 |
| Debts | - | - | 8.107 | 44.998 | 69.457 | 72.239 | 122.743 | 48.892 | 32.175 | 121.744 |
| Income in Advance | - | - | 0 | 40.866 | 99.357 | 223.021 | 361.367 | 367.111 | 478.392 | 420.149 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "124 - 124" | |||||||||
| CAEN Financial Year |
124
|
|||||||||
Comments - Livada Bio S.r.l.